Ipamorelin
Research Grade
$80
$80.00
1 × $80.00 pick 2 and save $8.00
Buy More Save More
Same day dispatch · free express shipping over $250
Certificates of Analysis
All certificates →Current batch · on shelf
99.47%
Purity by HPLC · identity confirmed by MS
17 August 2026
- Batch
- APL-IPA10-2608-03
- Net content
- 10.05 mg
- Specification
- ≥98.0% purity · passes
Every batch is analysed in-house by HPLC and mass spectrometry and ships with a batch-specific Certificate of Analysis. Independent third-party verification is added to select batches; none is published for Ipamorelin yet.
Molecular Details
Every batch is analysed in-house by HPLC & mass spectrometry and ships with a Certificate of Analysis; select batches are additionally verified by an independent third-party laboratory.
Usage & Storage
Description
Selective pentapeptide GH secretagogue targeting GHS-R1a. Studied in growth hormone release research with minimal cortisol and prolactin impact.
- Synthetic pentapeptide GH secretagogue (GHRP)
- Selective GHS-R1a (ghrelin receptor) agonist
- Studied without the cortisol/prolactin elevation of earlier GHRPs
- Investigated alongside GHRH analogues in GH-synergy research
- Research Grade purity >=98%
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (GHS) with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, identified by CAS number 170851-70-4. It acts as a selective agonist at the growth hormone secretagogue receptor 1a (GHS-R1a) — the same receptor targeted by endogenous ghrelin — and has been characterised in preclinical models for its capacity to stimulate growth hormone release from pituitary somatotrophs. Ipamorelin is distinguished within the GHRP class by its receptor selectivity: research has reported growth hormone release without the concurrent elevation of cortisol, prolactin or ACTH observed with earlier secretagogues such as GHRP-6 and hexarelin. Because it signals through the GHS-R1a and phospholipase C pathway rather than the GHRH receptor's cAMP cascade, it is frequently studied alongside GHRH analogues in synergy research, where the two independent cascades produce a greater-than-additive growth hormone response. Supplied as a lyophilised white powder with a molecular weight of 711.85 Da and molecular formula C38H49N9O5. Supplied strictly for in-vitro laboratory research. Not for human or veterinary consumption.
Frequently Asked Questions
Is Ipamorelin legal to buy in Australia?
Ipamorelin is supplied strictly as a research chemical for in-vitro laboratory use. It is not approved for human therapeutic use in Australia and is not for human or animal consumption. Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols.
What purity is Ipamorelin?
We specify ≥98% purity — the High-Tier Research Grade (commercial RUO) standard. Every batch is analysed in-house by HPLC and mass spectrometry and ships with a Certificate of Analysis; select batches also undergo independent, third-party purity verification.
Does Ipamorelin ship with a Certificate of Analysis (COA)?
Yes — every batch ships with a batch-specific COA documenting HPLC purity and mass-spectrometry identity. 3 Ipamorelin batch certificates are published in full at australianpeptidelabs.com.au/certificates/ipamorelin, so the analysis can be read before ordering and the batch number printed on the vial matched against it.
Where can I buy Ipamorelin in Australia?
Ipamorelin can be ordered here from Australian Peptide Labs for in-vitro research use, dispatched same day from within Australia with a COA included.
Do you provide dosing or administration guidance for Ipamorelin?
No. As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols. Our research library covers reconstitution and concentration calculations for in-vitro work.